Literature DB >> 9527963

Early postoperative glucose control predicts nosocomial infection rate in diabetic patients.

J J Pomposelli1, J K Baxter, T J Babineau, E A Pomfret, D F Driscoll, R A Forse, B R Bistrian.   

Abstract

OBJECTIVES: To determined the relationship between perioperative glucose control and postoperative nosocomial infection rate is 100 consecutive diabetic patients undergoing elective surgery. DESIGN AND PATIENTS: One hundred initially uninfected diabetic patients undergoing elective surgery were prospectively monitored for perioperative glucose control and postoperative nosocomial infection rate. Glucose control was determined by the attending surgeon or diabetologist.
SETTING: A large tertiary care hospital that serves as the in-patient facility for a local diabetes center. MAIN OUTCOME MEASURES: All patients were screened for infection preoperatively. Only initially uninfected patients were enrolled, and all patients received perioperative antibiotic coverage. Perioperative glucose control and postoperative nosocomial infection rate were monitored prospectively. APACHE II scores were determined on all patients. Patients were stratified into two groups: those with relatively "good" perioperative glucose control (all values < or = 220 mg/dL) and those with "poor" control (at least one value > 220 mg/dL). Contingency tables were generated, comparing nosocomial infection rates vs perioperative glucose control. Correlation coefficients between APACHE II score and maximum and mean glucose values were also determined.
RESULTS: A serum glucose > 220 mg/dL on postoperative day one (POD 1) was a sensitive (87.5%) but relatively nonspecific (33.3%) predictor of the later development of postoperative nosocomial infection. In patients with hyperglycemia (> 220 mg/dL) on POD 1, the infection rate was 2.7 times that observed (31.3% vs 11.5%) in diabetic patients with all serum glucose values < 220 mg/dL. When minor infection of the urinary tract was excluded, the relative risk for "serious" postoperative infection increased to 5.7 when any POD 1 blood glucose level was > 220 mg/dL. On the basis of correlation coefficients between serum glucose values and APACHE II score, only 18% of the variance in the highest serum glucose could be explained by disease severity alone.
CONCLUSIONS: We conclude that diabetic patients undergoing major cardiovascular or abdominal surgery have an increased risk of infection that is further exacerbated by early postoperative hyperglycemia. The high rate of nosocomial infection observed in diabetic patients with poor glucose control suggests that hyperglycemia itself may be an independent risk factor for the development of infection. Efforts to improve perioperative glucose homeostasis in diabetic patients may reduce the incidence of nosocomial infection and thereby improve outcome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9527963     DOI: 10.1177/014860719802200277

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  105 in total

Review 1.  Blood glucose management during critical illness.

Authors:  Barry A Mizock
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

2.  Preoperative evaluation and risk management.

Authors:  David P Parsons
Journal:  Clin Colon Rectal Surg       Date:  2009-02

Review 3.  Management of hyperglycemia in hospitalized patients.

Authors:  Dawn Smiley; Guillermo E Umpierrez
Journal:  Ann N Y Acad Sci       Date:  2010-10-29       Impact factor: 5.691

4.  Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease.

Authors:  E H Baker; C H Janaway; B J Philips; A L Brennan; D L Baines; D M Wood; P W Jones
Journal:  Thorax       Date:  2006-01-31       Impact factor: 9.139

Review 5.  Non-pharmacologic prevention of surgical wound infection.

Authors:  Daniel I Sessler
Journal:  Anesthesiol Clin       Date:  2006-06

6.  Standards of medical care in diabetes--2009.

Authors: 
Journal:  Diabetes Care       Date:  2009-01       Impact factor: 19.112

Review 7.  Peri-operative glycaemic control regimens for preventing surgical site infections in adults.

Authors:  Lillian S Kao; Derek Meeks; Virginia A Moyer; Kevin P Lally
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

8.  Sepsis-induced inflammation is exacerbated in an animal model of type 2 diabetes.

Authors:  Asha Jacob; Marissa L Steinberg; Juntao Yang; Weifeng Dong; Youxin Ji; Ping Wang
Journal:  Int J Clin Exp Med       Date:  2008-01-10

9.  Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial.

Authors:  Priyathama Vellanki; Neda Rasouli; David Baldwin; Sara Alexanian; Isabel Anzola; Maria Urrutia; Saumeth Cardona; Limin Peng; Francisco J Pasquel; Guillermo E Umpierrez
Journal:  Diabetes Obes Metab       Date:  2018-12-17       Impact factor: 6.577

10.  The classification of hospitalized patients with hyperglycemia and its implication on outcome: results from a prospective observational study in Internal Medicine.

Authors:  Filippo Pieralli; Cristina Bazzini; Alessia Fabbri; Carlotta Casati; Andrea Crociani; Francesco Corradi; Alberto Moggi Pignone; Alessandro Morettini; Carlo Nozzoli
Journal:  Intern Emerg Med       Date:  2015-11-26       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.